Pharmaceutical compositions comprising BI-1356 and metformin

Details for Australian Patent Application No. 2010302586 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Meinicke, Thomas

Agent Spruson & Ferguson

Pub. Number AU-A-2010302586

PCT Pub. Number WO2011/039367

Priority 09172117.5 02.10.09 EP

Filing date 1 October 2010

Wipo publication date 7 April 2011

International Classifications

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/522 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/039367 Priority application(s): WO2011/039367

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010302587-DLL4-binding molecules

2010302584-Anti inflammatory 2-oxothiazoles and 2 -oxooxazoles